The study findings demonstrate that the aflibercept biosimilar MYL-1701P is as effective and safe as the reference aflibercept in treating diabetic macular edema (DME), offering a promising option for ...

Korean drugmaker Celltrion plans to achieve annual sales of 5 trillion won ($3.58 billion) next year, driven by the growth of ...

India presently represents 3-4% of global biosimilar production, second to China and aims to increase it significantly. With ...

Zydus Lifesciences is exploring mergers, acquisitions, and licensing to bolster its specialty portfolio in the US, ...

Integrating IT with pharmaceuticals will further strengthen its role, paving the way for dominance in biologics and ...

HYDERABAD: Inaugurating the Indo-Belgian Life Sciences Conference in Hyderabad, Industries Minister D Sridhar Babu on Tuesday ...

The growing inclination for biologics and biosimilars is driving the sterile injectable contract manufacturing market.New York, USA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Market Overview: Polaris Market ...

The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...